In today's fast-paced world, many individuals struggle with respiratory issues, whether due to chronic conditions like asthma ...

In a recent study, Mass General Brigham researchers demonstrated that through low-cost genetic samples that can be obtained from a cheek swab or blood test, they can improve identification of people ...

The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

Researchers developed a new COPD-ES questionnaire for healthcare professionals to improve the management of stable chronic ...

The following is a summary of “Feasibility, Usability, and Pilot Efficacy Study of a Software-Enabled, Virtual Pulmonary ...

Pneumonia is a lung infection caused by bacteria, viruses, fungi, or tuberculosis. Symptoms include fever, cough, chest pain, ...

During and after an exacerbation, mental recovery involves taking care of both your physical and mental health. Resting, ...

“Patients with mild-to-moderate COPD who have low exercise tolerance are likely to experience poor respiratory health outcomes,” the investigators concluded. “Exercise tolerance may be considered one ...

Recognizing the signs of COPD, which include shortness of breath, chronic cough, and increased mucus production, can lead to a diagnosis and treatment plan that improves the chances of slowing ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these ...

The study included a 6-week screening period, 52 weeks of treatment, and a 12-week safety follow-up. The annualized rate of moderate or severe COPD exacerbations for 52 weeks was the primary endpoint.

While COPD is not curable, it is a preventable and treatable illness. The earlier you start treatment, the better your prognosis. COPD is often asymptomatic until significant damage to the lungs has ...